Cadrenal Therapeutics (CVKD) Insider Trading & Ownership $13.15 -0.35 (-2.59%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$13.55 +0.40 (+3.04%) As of 09/12/2025 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cadrenal Therapeutics (NASDAQ:CVKD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.09%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$98.34K Get CVKD Insider Trade Alerts Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVKD Insider Buying and Selling by Quarter Cadrenal Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/28/2025Matthew K SzotCFOSell400$14.00$5,600.00 8/28/2025Quang X PhamCEOSell1,193$13.99$16,690.07 8/27/2025Matthew K SzotCFOSell1,600$13.99$22,384.00 8/27/2025Quang X PhamCEOSell3,836$13.99$53,665.64 (Data available from 1/1/2013 forward) CVKD Insider Trading Activity - Frequently Asked Questions Who is on Cadrenal Therapeutics' Insider Roster? The list of insiders at Cadrenal Therapeutics includes John Raymond Murphy, Matthew K Szot, and Quang X Pham. Learn more on insiders at CVKD. What percentage of Cadrenal Therapeutics stock is owned by insiders? 26.09% of Cadrenal Therapeutics stock is owned by insiders. Learn more on CVKD's insider holdings. Which Cadrenal Therapeutics insiders have been buying company stock? The following insider purchased CVKD shares in the last 24 months: John Raymond Murphy ($12,131.70). How much insider buying is happening at Cadrenal Therapeutics? Insiders have purchased a total of 17,331 CVKD shares in the last 24 months for a total of $12,131.70 bought. Which Cadrenal Therapeutics insiders have been selling company stock? The following insiders have sold CVKD shares in the last 24 months: Matthew K Szot ($27,984.00), and Quang X Pham ($70,355.71). How much insider selling is happening at Cadrenal Therapeutics? Insiders have sold a total of 7,029 Cadrenal Therapeutics shares in the last 24 months for a total of $98,339.71 sold. Cadrenal Therapeutics Key ExecutivesMr. Quang X. Pham (Age 59)Chairman & CEO Compensation: $967k2 recent tradesMr. Matthew K. Szot CPA (Age 50)CPA, Chief Financial Officer Compensation: $594.89k2 recent tradesDr. Douglas W. Losordo FACC (Age 66)FAHA, M.D., Chief Medical Officer Compensation: $528.69kMr. Jeffrey ColeChief Operating Officer More Insider Trading Tools from MarketBeat Related Companies MGNX Insider Trading PLRX Insider Trading SAVA Insider Trading HLVX Insider Trading ATOS Insider Trading COYA Insider Trading TCRX Insider Trading ANRO Insider Trading SRZN Insider Trading EXOZ Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:CVKD) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVKD Stock Alerts